Rett syndrome is characterized by normal development for the first 6-18 months of life followed by the loss of fine and gross motor skills and the ability to engage in social interaction. In most patients, mutations are found in methyl CpG-binding protein 2 (MECP2) gene.
Introduction
Rett syndrome is a X-linked progressive brain developmental disorder and one of the most common causes of mental retardation in females first described in the 1960s by Andreas Rett (1) .
Girls affected with classic form of Rett syndrome (RTT) seem to have normal development for 6 to 18 months. This course then followed by the loss of acquired fine and gross motor skills and the ability to engage in social interaction. Abnormal stereotypic hand movements may also occur. Rett syndrome primarily affects females and has an incidence of 1:10000 at birth until the age of 12 years (2).
Rett syndrome has two main types: classic and atypical. These two types may be characterized by their symptoms or specific gene mutations, and most patients with Rett syndrome have a classic form (3) .
Mutations in the X-linked gene methyl CpGbinding protein 2 (MECP2) have been found in the majority of patients. MeCP2 is a protein that is critical for normal brain function. This protein is involved in maintaining synapses between nerve cells (4) .
The mutations in the gene encoding MECP2 are associated with rare familial cases of RTT as well as in the usual sporadic cases of typical RTT (4) .
Using modern mutation detection tests, n 70%-80% of patients with typical RTT mutations are found in MECP2 (5) . In addition to RTT, mutations in MECP2 have also been identified in cases with no clinical features of RTT.
Mutations are in the X-linked gene MECP2, which encodes MeCP2 protein. MeCP2 is a member of family of methyl-CpG-binding domain proteins (MBD), but with their unique differences that help put it apart from the group. More than 600 MECP2 mutations have been identified, including missense, nonsense, frameshift and large deletion mutations that are pathogenic effect (RettBase; http://mecp2.
chw.edu.au/). Most of these changes in MECP2
gene cause RTT in heterozygous females, but there is allelic heterogeneity in this disorder and a range of MECP2 mutations associated with variable phenotypic outcomes, including milder forms of learning disability and, rarely, autism, are also known (4, 6) . MECP2 has two functional domains, a methylcytosine-binding domain (MBD) with composition of 85 amino acids and a transcriptional repression domain (TRD) which has 103 amino acids. The MBD domain binds to the methylation sites of CpG in the DNA strands and then TRD region makes reaction with SIN3A to utilize histone deacetylases (HDAC). There are also two high mobility group protein-like domains. The unusual, repetitive sequences are found at the carboxyl terminus (7, 8) .
At one end of the spectrum, asymptomatic female carriers are found in familial RTT (11 (9) .
In addition to MECP2 mutations, cyclin-dependent kinase-like 5 (CDKL5) and Netrin G1, two other genes have recently been known in patients with clinical phenotype of Rett syndrome (10) (11) (12) (13) (14) . We felt that Rett syndrome patients were not well studied in Iran. Therefore, we examined these patients based on the two main principals mentioned above to determine the spectrum of mutation in patients with Rett syndrome. Finally, the reaction products were sequenced and examined by Chromas program.
Materials & Methods

Patients and samples
Statistics
Having gathered patients' data and molecular results, descriptive correlation between genotype and phenotype was finally investigated.
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Results
Of 27 patients who met the inclusion criteria, 23
accepted to participate in the study. The mean age of 23 included patients in study was 5.2 yr with SD:
±2.13. The minimum and maximum age was 2, and 10 yr, respectively. The age of onset for signs and symptoms was ranged mostly less than 18 months (87%) and only 3 of 23 patients (13%) had shown their signs and symptoms in the range of [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] months. According to the chart brought in methods section, the severity of signs and symptoms were defined from 0 (less sever) to 3 (most sever) pluses ( Of all 13 patients who showed epilepsy, MECP2 positive patients were more prone to have epilepsy.
Eight epileptic patients had MECP2 mutation and the remaining 5 had not any evidence for MECP2 mutation. However, severity of epilepsy (uncontrolled seizures) was not related to MECP2.
Similar results were seen in EEG abnormalities.
Hand use, psychomotor retardation and communication problems were seen in all patients either in MECP2 positives or negatives. Autonomic dysfunction was seen in 7 patients that only one of them had MECP2 mutation and other 6 ones had no evidence of mutation. MEPC2 gene mutation was studied for each patient too. Ten patients showed evidence of nucleotide changes including missense, nonsense or frameshift. The rest of patients did not show any evidence of changes. The detail of the changes detected for each patient is brought in Table 5 and Table 5 for an explanation of the details of each mutation. Table 5 for an explanation of the details of each mutation.
Discussion
In this study, we reported the results of mutational analysis for MECP2 gene in Iranian affected RTT girls. To our knowledge, this was the first time that Rett patients were studied in both clinical manifestations and genetic changes in Iran. About 47% of patients participated in our study showed MECP2 mutation including missense, nonsense or frame shift.
The rate of mutation detection in our study is equal to some previously reported rates such as the 50% detection rate. It confirms the major role of MECP2 gene mutation in etiology of Iranian patients too (16) . On the other hand, there is a difference comparing to findings of another study where nearly 70%-80% of females with Rett's syndrome had these mutations within the MECP2 gene (5) .
Of note, MECP2 positivity differs in various countries, as De novo mutations were found in 60% of the patients in Spain which is closer to our findings (17) . This difference is also referred to the limited number of patients studied in such studies and a series of patient who refused to participate like happened in our research. This reason could explain when comparing the results of a study in Japan in which 19 disease mutations (73%) were identified in 26 Japanese Rett patients (18) .
The mutational diversity in our patients is consistent with the findings of other studies (16) (17) (18) . In our study, about 10% of mutations were intragenic deletions or complex rearrangements that lead to frameshifts. In our study, of 10 MECP2 positive mutations, we detected one case with frameshift in the C-terminal region.
Moreover, the majority of mutations was C>T transitions which were nearly 70% of all identified mutations. Similarly, the majority of mutations in our study was C>T transitions too which was about 50% in another study (19) .
The p.V288M amino acid change is identified as the most common mutational hotspot in our study.
However, this mutation is not included in common formerly recognized hot spots. This is a new finding in patients with Rett syndrome in Iranian population.
In a previous study, 70% of the mutations within MECP2 were in eight hotspots which affect translation of the amino acids including R106, R133, T158, R168, R255, R270, R294, and R306 (20) .
According to patients' signs and symptoms, despite in some items like epilepsy and EEG abnormalities, MECP2 positives showed slightly higher rates compared to those without mutations, and autonomic dysfunctions were more seen in MECP2 negatives, but none of them revealed significant correlation between signs and mutations. are involved in the repression of transcription of target genes, but the mechanism of TRD repression is unknown (21) .
The study of genotype-phenotype correlation requires precise investigations in larger group of patients to determine correlation with various types of mutations.
Genotype-phenotype correlation has been investigated, but it is complex by MECP2 gene X-chromosome inactivation. This inactivity allows a mother with a mutation of MECP2 to have a normal phenotype because of skewing of X-chromosome inactivation (22) . In contrast to the problems with X-chromosome inactivation, many studies of genotype-phenotype correlations exist (17, 22, 23) . More studies must be carried out to investigate more case to find better conclusions. 
In conclusion
